Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 15/20 | 0.42 |
| ▸ | PPARD | Q03181 | 13/20 | 0.42 |
| ▸ | PPARG | P37231 | 7/20 | 0.42 |
| ▸ | ACACB | O00763 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2525920 | 0.89 | MEN1 (0.47) | MEN1KMT2APPARAPPARDPPARG | |
| SCHEMBL28599117 | 0.78 | SLC7A5 (0.51) | PPARAPOLB | |
| SCHEMBL10540538 | 0.78 | SLC7A5 (0.51) | PPARAPOLB | |
| SCHEMBL1944103 | 0.78 | LDHA (0.57) | MEN1KMT2APPARAPPARDPPARG | |
| SCHEMBL524638 | 0.77 | ITGB3 (0.59) | MEN1KMT2ANPC1RAB9AMAPT | |
| Water SCHEMBL2521640 | 0.77 | SLC7A5 (0.50) | PPARAPOLB | |
| SCHEMBL455152 | 0.77 | ITGB3 (0.59) | MEN1KMT2ANPC1RAB9AMAPT | |
| SCHEMBL8970225 | 0.77 | FFAR1 (0.49) | MEN1KMT2APPARAPPARDPPARG | |
| SCHEMBL9784912 | 0.77 | ITGB3 (0.59) | MEN1KMT2ANPC1RAB9AMAPT | |
| SCHEMBL29633941 | 0.77 | ALDH1A1 (0.38) | PPARAPPARDPPARGNPC1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110312875-A1 | PEPTIDIC COMPOUNDS | UNIVERSITY OF WOLLONGONG (AU) | 2011-12-22 | — | — | US | disclosed |
| US-8039430-B2 | Peptidic compounds | UNIVERSITY OF WOLLONGONG (AU) | 2011-10-18 | — | — | US | disclosed |
| US-20080300287-A1 | Peptidic Compounds | UNIVERSITY OF WOLLONGONG (AU) | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080300287-A1 | Peptidic Compounds | VIP, NGLY1, FURIN | MEN1 1669/4885KMT2A 4643/4885PPARA 3838/4885 |
| US-20110312875-A1 | PEPTIDIC COMPOUNDS | VIP, NGLY1, FURIN | MEN1 1571/4885KMT2A 4562/4885PPARA 3696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.